Sök artiklar i SveMed+

Observera: SveMed+ upphör att uppdateras!



Cytotoksiske nukleosidanaloger - metabolisme, virkemåte og resistens
Engelsk titel: Cytotoxic nucleoside analogues - metabolism, activity and resistance Läs online Författare: Jordheim LP Språk: Nor Antal referenser: 30 Dokumenttyp: Översikt UI-nummer: 05091588

Tidskrift

Tidsskrift for Den Norske Laegeforening 2005;125(17)2348-50 ISSN 0029-2001 E-ISSN 0807-7096 KIBs bestånd av denna tidskrift Denna tidskrift är expertgranskad (Peer-Reviewed)

Sammanfattning

MATERIAL AND METHODS : An overview of cytotoxic nucleoside analogues, their metabolism and their mechanism of action is presented. Studies on resistance to nucleoside analogues are reviewed. Results were collected from the literature in the PubMed database and from research in our laboratory. BACKGROUND : Cellular resistance is an increasing problem in the treatment of haematological malignancies and solid tumours with cytotoxic nucleoside analogues. Studies on cellular models and clinical samples have allowed insight into the mechanisms behind this resistance. RESULTS AND INTERPRETATION : Variations in the activity of nucleoside transporters and proteins of the intracellular metabolism are implicated in the result of treatment with nucleoside analogues. These proteins are kinases, 5'-nucleotidases and deaminases. Mechanisms identified in cell models or in samples from non-responding patients should be validated in treated patients. These mechanisms are prognostic factors for the clinical outcome in nucleoside analogue-treated patients.